Inhibition of EMT, inhibiting TGF-β1 activity and SMAD pathway [56]  250 specimens from lung cancer patients, 51 of whom were treated with statins (mainly simvastatin), revealed an improved prognosis [58]. This evidence concerns the gene TGFB1 and lung carcinoma.